Cycrimine
Clinical data | |
---|---|
License data |
|
ATC code |
|
Identifiers | |
| |
JSmol) | |
| |
|
Cycrimine (trade name Pagitane) is a central anticholinergic drug designed to reduce the levels of acetylcholine in the treatment of Parkinson's disease. Its mechanism of action is to bind to the muscarinic acetylcholine receptor M1.[1]
Synthesis
See also
References
- OCLC 715151908.
- .
External links
- Cycrimine at DrugLib.com